That is correct.
Just to clarify, under the Food and Drugs Act and regulations, if a manufacturer of, say, an e-cigarette or any health product wants to gain market access, it's up to them to carry out the research to demonstrate that the product has efficacious effects on the disease they're trying to treat, that it doesn't introduce unrealistic or intolerable safety issues, and that it can produce a product in predictable quality. In getting market access in the current framework in Canada, it's up to the manufacturers to develop that evidence and bring it in to the regulator. If it's reviewed and felt to be acceptable for a proposed indication, then it will get a market authorization.